The project aims to improve the pharmacovigilance and the report from the adverse events derivative from the drug use for treatment of heart failure. This will occur through the analysis of reported adverse events compared to those not reported throughout the years. In addition, factors associated with reported adverse events, especially fatal ones, will be […]
Read More